Clinical Trial Information

Phase 2, Randomized, Prospective, Open Label, Parallel-Arm, Dose Optimization Study to Investigate the Safety, Tolerability, PK/PD, and Anti-Tumor Effect of 2X- 121 in Patients with Recurrent, Advanced Ovarian Cancer

Protocol Number: 2X-1002
Status: Open
Age Group: Adult
Treatment Type: Treatment
Phase: II
NCT ID: NCT03878849

Scope Information

Scope:: National
Disease Site(s):: Ovary